Clindamycin dosing for cellulitis

Adjunctive Clindamycin for Cellulitis: Clinical trial comparing flucloxacillin with or without clindamycin for the treatment of limb cellulitis (C4C Trial)

Low-dose clindamycin therapy is an alternative suppressive regimen. KEY b) For concomitant cellulitis, use intravenous clindamycin, nafcillin

Inadequate dosing of clindamycin and TMP/SMX is independently associated with clinical failure in patients hospitalized with cellulitis. Further prospective studies evaluating weight-based dosing of clindamycin and TMP/SMX in the setting of cellulitis are warranted.

Adjunctive Clindamycin for Cellulitis: Clinical trial comparing flucloxacillin with or without clindamycin for the treatment of limb cellulitis (C4C Trial)

SKIN AND SOFT TISSUE INFECTION (SSTI) (AKA ABSCESS/CELLULITIS) Rapidly progressing cellulitis Clindamycin 10mg/kg/dose TID x 7 days. MAX

Cellulitis (treatment of choice for non-purulent cellulitis). clindamycin dosing. 900 mg IV q8hr. Generally no dose adjustment for

Cellulitis (treatment of choice for non-purulent cellulitis). clindamycin may cause more Clostridioides difficile than IV clindamycin.

Low-dose clindamycin therapy is an alternative suppressive regimen. KEY b) For concomitant cellulitis, use intravenous clindamycin, nafcillin

Adjunctive clindamycin for cellulitis: clinical trial comparing flucloxacillin with or without clindamycin for the treatment of limb cellulitis Clinical Trial